Patterson Companies (PDCO)
(Delayed Data from NSDQ)
$26.02 USD
+0.26 (1.01%)
Updated May 7, 2024 04:00 PM ET
After-Market: $26.04 +0.02 (0.08%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.02 USD
+0.26 (1.01%)
Updated May 7, 2024 04:00 PM ET
After-Market: $26.04 +0.02 (0.08%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth A Momentum B VGM
Zacks News
What's in Store for Patterson Companies' (PDCO) Q4 Earnings?
by Zacks Equity Research
Patterson's (PDCO) Dental segment likely to see a soft Q4; a downbeat guidance raises concern.
What Makes Patterson Companies (PDCO) a Strong Sell?
by Zacks Equity Research
Patterson Companies (PDCO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Patterson Companies (PDCO) Down 7.8% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Patterson Companies (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson Companies (PDCO) Misses on Q3 Earnings, Cuts View
by Zacks Equity Research
Lower sales and gross-margin compression mars Patterson Companies' (PDCO) results in Q3.
Patterson Companies (PDCO) Q3 Earnings: What's in Store?
by Zacks Equity Research
Diverse product portfolio and strong veterinary business prospects to drive Patterson Companies (PDCO) in Q3. However, sluggishness in the Dental-Supply segment is a woe.
Top Ranked Income Stocks to Buy for February 26th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, February 26th:
Top Ranked Income Stocks to Buy for February 16th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 16th:
Top Ranked Income Stocks to Buy for February 13th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, February 13th:
Top Ranked Income Stocks to Buy for February 12th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 12th:
Top Ranked Income Stocks to Buy for February 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 2nd:
Top Ranked Income Stocks to Buy for February 1st
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 1st:
Top Ranked Income Stocks to Buy for January 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 31st:
Top Ranked Income Stocks to Buy for January 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 31st:
Top Ranked Income Stocks to Buy for January 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 23rd:
Patterson Companies' (PDCO) Dental Segment Shows Weakness
by Zacks Equity Research
Changing healthcare environment in the United States, unfavorable price movements and competitive dental products industry are posing challenges for Patterson Companies, Inc. (PDCO).
Patterson Companies (PDCO) Up 4.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Patterson Companies (PDCO) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson Companies-SprintRay Deal to Boost Dental Unit
by Zacks Equity Research
Patterson Companies (PDCO) focuses on acquisitions to boost dental segment.
Patterson Companies Dental Business Dull, Competition Rife
by Zacks Equity Research
Patterson's (PDCO) dental segment sales have been weak. The company faces stiff competition from at least 15 full-service distributors and small distributors.
What Falling Estimates & Price Mean for Patterson Companies (PDCO)
by Zacks Equity Research
It seems to be a wise decision for investors to drop Patterson Companies (PDCO) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.
Here's Why You Should Invest in Align Technology (ALGN) Now
by Zacks Equity Research
Align Technology (ALGN) continues to boost investors' confidence on consistent strength in InvisAlign.
Patterson Companies (PDCO) Misses on Q2 Earnings, Cuts View
by Zacks Equity Research
Patterson Companies (PDCO) missed estimates for both the counts in Q2. A downbeat guidance indicates looming concerns.
Patterson Companies (PDCO) Misses on Earnings & Sales in Q2
by Zacks Equity Research
Patterson Companies ended the second quarter of fiscal 2018 on a tepid note, missing the Zacks Consensus Estimate on both the counts.
Align Technology-Glidewell Dental Deal to Boost iTero Uptake
by Zacks Equity Research
Align Technology (ALGN) progresses with deals to boost the Scanners and Services segment.
Patterson Companies (PDCO) Q2 Earnings: What's in Store?
by Zacks Equity Research
Patterson Companies' (PDCO) solid dental segment is a positive. The company anticipates troubles in its technology equipment business to persist through fiscal 2018.
Will Invisalign Drive Align Technology's (ALGN) Q3 Earnings?
by Zacks Equity Research
Align Technology (ALGN) is poised to gain from strength in the Invisalign space in Q3.